The Guardian
Email YouTube Facebook Instagram Twitter WhatsApp
Everything you need to live well
x

UK Lab To Pay Volunteers £3,500 To Be Infected With Coronavirus

For £3,500 the participants will be injected with two common strains of the coronavirus which are believed to cause very mild respiratory symptoms that are not as severe as COVID-19 | Image: horizon-magazine

In a bid to find a vaccine for COVID-19 otherwise known as coronavirus which continues to spread around the world, a laboratory is now offering people £3,500 (₦1,675,566.55) to be infected with a form of the disease.

According to the Daily Mail, the Queen Mary BioEnterprises Innovation Centre will reportedly be infecting up to 24 people at a time with two weaker strain of coronavirus strains as part of a global experiment.

x

For £3,500 the participants will be injected with two common strains of the virus known as 0C43 and 229E which are believed to cause very mild respiratory symptoms that are not as severe as COVID-19.

During the study, participants will spend two weeks in isolation, eat a restricted diet and will not be able to exercise or have physical contact with other people.

They will undergo a series of examinations during that time, including nasal swabs and blood tests, while medical staff in protective clothing will collect any dirty tissues they infect. Doctors working on the study will assess their response to the vaccine while wearing protective clothing and ventilators.

Around 35 vaccine candidates have been listed by the World Health Organization (WHO). The testing is part of a $2bn global effort to find a vaccine for coronavirus, as Europe has experienced a huge surge in cases in the past two weeks.

Cathal Friel, executive chairman of Hvivo’s parent company, Open Orphan, says the company is at the ‘forefront of the fight against the outbreak’. Other drugmakers across the globe are also starting their own participant studies into coronavirus, with scientists in Seattle calling on healthy volunteers to participate in a 14-month trial.

The study, launched by Moderna Therapeutics, will start at the end of April, and participants will not need to be quarantined, The Wall Street Journal reports. Volunteers will receive around $1,100 (£836) for taking part.

Those interested in the study at Queen Mary BioEnterprises Innovation Centre can visit Hvivo’s website, FluCamp.com.

Meanwhile, the coronavirus as so far killed more than 4,000 people globally and infections are at over 114,000.

In this article:
CoronavirusCOVID-19
Receive News Alerts on Whatsapp: +2348136370421

Related